Acid suppressive agents and risk of Mycobacterium Tuberculosis: case–control study

BackgroundThe acid-suppressive agents have been linked with an increased risk of infectious disease. The relationship between these drugs and Mycobacterium Tuberculosis (TB) was not been reported.MethodsWe conducted a case–control study using data from National Health Insurance research database of Taiwan. From 1996 till 2008, and 6541 cases were defined as TB infection/activation (ICD-9 coding plus prescription two of four first-line anti-TB regimen for at least one month). Control subjects who were matched to the TB cases by age and sex were selected with 10:1 ratio. Medical records including acid-suppressive agent prescription and comorbidity, and socioeconomic status were analyzed.ResultsTB infection/activation was more frequent to comorbidity with chronic diseases, alcohol abuse, malignancy, immune deficient/suppression status and acid-related disease (peptic ulcer, reflux esophagitis). Among the TB cases, there was higher exposure record to acid-suppressive agents within 3 months before TB index date (OR 2.43(2.06-2.88) and 1.90 (1.68-2.14) for proton pump inhibitor (PPI) and histamine 2 receptor antagonist (H2RA) respectively). After adjusting confounding factors, PPIs prescription 3 months before TB index date had an association of TB infection/activation (adjusted OR 1.63(1.61-1.63)). Similar result was found in H2RA user (adjusted OR 1.51(1.50-1.52)). The association of acid-suppressive agents in TB infection/activation was fade gradually when the drug prescription period extended.ConclusionsRecent prescription of acid-suppressive agent seems to associate the TB infection/activation. In the society where TB was prevalent, evaluation of pulmonary TB before prescription of PPI or H2RA is warranted.

• Publication year

  2014

• Venue

  BMC Gastroenterology

• Publication date

  2014-05-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/1471-230X-14-91PMID 24884853PMCID 4030068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India

  2013cited by this paper
• Increased risk of tuberculosis after gastrectomy and chemotherapy in gastric cancer: a 7-year cohort study

  2011cited by this paper
• Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.

  2010cited by this paper
• Proton pump inhibitor use and the risk of community-acquired pneumonia.

  2010cited by this paper
• Tuberculosis in the global aging population.

  2010cited by this paper
• WHO global tuberculosis control report 2010. Summary.

  2010cited by this paper
• Increasing drug resistance of Mycobacterium tuberculosis in a medical center---what about in Taiwan overall?

  2009cited by this paper
• Risk of community‐acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population‐based case–control study

  2009cited by this paper
• Acid Inhibition and Infections Outside the Gastrointestinal Tract

  2009cited by this paper
• Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

  2009cited by this paper
• First attack of acute pancreatitis in Sweden 1988 – 2003: incidence, aetiological classification, procedures and mortality – a register study

  2009cited by this paper
• Acid-suppressive Drugs and Community-acquired Pneumonia

  2009cited by this paper
• Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites

  2009cited by this paper
• Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis.

  2009cited by this paper
• CLINICAL IMPLICATIONS OF CHRONIC THERAPY FOR GERD

  2009cited by this paper
• Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia

  2008cited by this paper
• Use of acid-suppressing drugs and the risk of bacterial gastroenteritis.

  2007cited by this paper
• Selected biological and behavioural risk factors associated with pulmonary tuberculosis.

  2007cited by this paper
• Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.

  2007cited by this paper
• Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile–Associated Disease

  2006cited by this paper
• Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs

  2006cited by this paper
• Mycobacterium tuberculosis in Taiwan.

  2006cited by this paper
• Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan.

  2005cited by this paper
• Etiology of Community-Acquired Pneumonia

  2005cited by this paper
• Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

  2005cited by this paper
• Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

  2004cited by this paper
• Tuberculosis associated with gastrectomy

  2004cited by this paper
• Overuse of acid suppressant drugs in patients with chronic renal failure.

  2003cited by this paper
• Trends in prescribing proton pump inhibitors in Taiwan: 1997 - 2000.

  2003cited by this paper
• Utilización de supresores de la secreción ácida en pacientes hospitalizados

  2002cited by this paper
• [Use of acid-suppressive medications in hospitalized patients].

  2002cited by this paper
• Overuse of acid-suppressive therapy in hospitalized patients

  2000cited by this paper
• Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control.

  2000cited by this paper
• Clinical Investigations: Infections: Journal Article: Research Support, Non-U.S. Gov'tEtiology of Community-acquired Pneumonia: Evaluation by Transtracheal Aspiration, Blood Culture, or Serology

  1993cited by this paper
• Pulmonary tuberculosis after gastric resection.

  1976cited by this paper
• Tuberculosis occurring after gastrectomy.

  1956cited by this paper
• Peptic Ulcer, Partial Gastrectomy, and Pulmonary Tuberculosis

  1956cited by this paper

• Association of acid-suppressive therapy and tuberculosis: A causal or coincidental link to the infection?

  2024cites this paper
• META-ANALISIS FAKTOR RISIKO INTERNAL DAN KOMORBID YANG BERHUBUNGAN DENGAN KEJADIAN PENYAKIT TUBERKULOSIS DI WILAYAH ASIA

  2024cites this paper
• The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance

  2023cites this paper
• Determinants of tuberculosis in Central Region of Eritrea: a matched case-control study

  2023cites this paper
• Burden of comorbidities and their treatment in patients with active tuberculosis: A prospective study

  2021cites this paper
• Mycobacterium vaccae Adaptation to Disinfectants and Hand Sanitisers, and Evaluation of Cross-Tolerance with Antimicrobials

  2020cites this paper
• Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs

  2020cites this paper
• The association between proton pump inhibitor use and the risk of tuberculosis: A case‐control study

  2019cites this paper
• Association between pulmonary tuberculosis and acid suppressive agents

  2019cites this paper
• Gastric Tuberculosis.

  2019cites this paper
• Gastro Oesophageal Reflux and Bronchiectasis

  2018cites this paper
• Mycobacterial Response to Organic Solvents and Possible Implications on Cross-Resistance With Antimicrobial Agents

  2018cites this paper
• Use acid-suppressing drugs appropriately with an individualized approach to minimize the risk of infection

  2018cites this paper
• Diabetes mellitus increased all-cause mortality rate among newly-diagnosed tuberculosis patients in an Asian population: A nationwide population-based study.

  2017cites this paper
• Acid-Suppressive Therapy and Risk of Infections: Pros and Cons

  2017cites this paper
• Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease

  2017cites this paper
• Use acid-suppressing drugs appropriately with an individualized approach to minimize the risk of infection

  2017cites this paper
• Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan

  2017influential citation
• Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort

  2017cites this paper
• Characteristics and Treatment Outcomes of New Pulmonary Tuberculosis Patients with Comorbidities in the Samarkand Region, Uzbekistan

  2016cites this paper
• Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease.

  2016cites this paper
• Aetiological spectrum of benign gastric outlet obstruction in India: new trends

  2016influential citation
• Treatment and Replenishment of G.I. Tract with Combined Regimen Therapy (CRT) of Allopathic (PPIs) and Ayurvedic (Aloe Vera) Medicine in Peptic Ulcer Disease to Counteract Relapse

  2015cites this paper
• Gastric secretion

  2014cites this paper